A Single Arm, Phase I/II Trial of Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men with Localized, High Risk Prostate Cancer Big Ten Cancer Research Consortium BTCRC-GU19-404

Learn more:

• clinicaltrials.gov: #NCT04737109
• See Study Locations on Big Ten CRC Website